Save your place

Sign in to WhoBought

Please try again later.

Cathie Wood's UroGen Pharma Ltd. (URGN) position

Yes: as of Q1 2026, Cathie Wood holds 116K shares of URGN worth an amount we cannot price (0.0% of the disclosed portfolio). Held since at least Q1 2021; that opening coverage snapshot is not counted as a purchase.
View full portfolio →
Current value
an amount we cannot price
Shares held
116K
% of portfolio
0.0%
Quarter-end price
No quarter-end price available

Average buy price is hidden here because at least one covered purchase quarter has no usable local mean price.

URGN price vs Wood's position

Dates
← Earlier —7 purchases, 13 sells354045
Average closing price · filing quarter
Price range · filing quarter

Every quarterly change

Every quarterly change
Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Reduced· Q1 2026 −6K
Quarter Q1 2026 Δ Own −4.9% Shares held 116K Filing date May 12, 2026
Q1 2026 Reduced· Q1 2026 −6K −4.9% 116K May 12, 2026
Reduced· Q4 2025 −5K
Quarter Q4 2025 Δ Own −4.1% Shares held 121K Filing date Feb 11, 2026
Q4 2025 Reduced· Q4 2025 −5K −4.1% 121K Feb 11, 2026
Reduced· Q3 2025 −39K
Quarter Q3 2025 Δ Own −23.7% Shares held 127K Filing date Nov 12, 2025
Q3 2025 Reduced· Q3 2025 −39K −23.7% 127K Nov 12, 2025
Reduced· Q2 2025 −20K
Quarter Q2 2025 Δ Own −10.6% Shares held 166K Filing date Jul 30, 2025
Q2 2025 Reduced· Q2 2025 −20K −10.6% 166K Jul 30, 2025
Added· Q1 2025 +46K
Quarter Q1 2025 Δ Own +32.6% Shares held 186K Filing date May 7, 2025
Q1 2025 Added· Q1 2025 +46K +32.6% 186K May 7, 2025
Added· Q4 2024 +19K
Quarter Q4 2024 Δ Own +15.2% Shares held 140K Filing date Feb 4, 2025
Q4 2024 Added· Q4 2024 +19K +15.2% 140K Feb 4, 2025
Reduced· Q3 2024 −30K
Quarter Q3 2024 Δ Own −19.9% Shares held 122K Filing date Oct 31, 2024
Q3 2024 Reduced· Q3 2024 −30K −19.9% 122K Oct 31, 2024
Added· Q2 2024 +5K
Quarter Q2 2024 Δ Own +3.7% Shares held 152K Filing date Jul 26, 2024
Q2 2024 Added· Q2 2024 +5K +3.7% 152K Jul 26, 2024
Reduced· Q1 2024 −15K
Quarter Q1 2024 Δ Own −9.4% Shares held 146K Filing date Apr 18, 2024
Q1 2024 Reduced· Q1 2024 −15K −9.4% 146K Apr 18, 2024
Reduced· Q4 2023 −54K
Quarter Q4 2023 Δ Own −25.0% Shares held 162K Filing date Jan 17, 2024
Q4 2023 Reduced· Q4 2023 −54K −25.0% 162K Jan 17, 2024
Added· Q3 2023 +13K
Quarter Q3 2023 Δ Own +6.6% Shares held 215K Filing date Oct 18, 2023
Q3 2023 Added· Q3 2023 +13K +6.6% 215K Oct 18, 2023
Reduced· Q2 2023 −69K
Quarter Q2 2023 Δ Own −25.4% Shares held 202K Filing date Jul 10, 2023
Q2 2023 Reduced· Q2 2023 −69K −25.4% 202K Jul 10, 2023
Added· Q1 2023 +74K
Quarter Q1 2023 Δ Own +37.5% Shares held 271K Filing date Apr 17, 2023
Q1 2023 Added· Q1 2023 +74K +37.5% 271K Apr 17, 2023
Reduced· Q4 2022 −85K
Quarter Q4 2022 Δ Own −30.1% Shares held 197K Filing date Jan 24, 2023
Q4 2022 Reduced· Q4 2022 −85K −30.1% 197K Jan 24, 2023
Reduced· Q3 2022 −20K
Quarter Q3 2022 Δ Own −6.8% Shares held 282K Filing date Oct 17, 2022
Q3 2022 Reduced· Q3 2022 −20K −6.8% 282K Oct 17, 2022
Data through Q1 2026 · filed May 12, 2026
15 of 21

More Wood positions

Common questions

Does Cathie Wood own URGN?

Yes. As of Q1 2026, Cathie Wood disclosed 116K shares of URGN, worth an amount we cannot price. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Cathie Wood buy URGN?

Cathie Wood held URGN since at least Q1 2021, when this filing coverage begins; the opening snapshot is not a disclosed purchase. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Cathie Wood sell URGN?

The quarter-by-quarter table above shows each sale and reduction Cathie Wood disclosed in URGN. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of URGN does Cathie Wood own?

Cathie Wood disclosed 116K shares of URGN as of Q1 2026. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Cathie Wood pay for URGN?

Cathie Wood began building the URGN position before our 13F history starts, so an exact average buy price cannot be estimated without understating it. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.